AGE and RAGE inhibitors in the treatment of diabetic retinopathy

被引：7

作者：

Bhatwadekar, Ashay ^{[1
]}

Stitt, Alan W. ^{[1
]}

机构：

[1] Queens Univ Belfast, Royal Victoria Hosp, Ctr Vis Sci, Belfast BT12 6BA, Antrim, North Ireland

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2007年 / 2卷 / 01期

基金：

英国惠康基金;

关键词：

advanced glycation end products; diabetic retinopathy; receptor for advanced glycation end products;

D O I：

10.1586/17469899.2.1.105

中图分类号：

R77 [眼科学];

学科分类号：

100212 [眼科学];

摘要：

Diabetic retinopathy is a major complication of diabetes and several biochemical/molecular mechanisms have been proposed as key instigators in the initiation and progression of the condition. Accumulating evidence suggests that formation of advanced glycation end products (AGEs) within the diabetic milieu is one of the contributing factors to neural and microvascular abnormalities as retinopathy progresses. This review highlights the pathogenesis of diabetic retinopathy, with special emphasis on AGEs, their receptors and the potential role of AGE-inhibiting agents. Retinopathy may be associated with an upregulation of the receptor for AGEs (RAGE) in a proinflammatory axis, concomitant with increases in AGEs. Therefore, this review will also detail the role of RAGE in AGE trafficking, its various ligands and the possibilities for targeting RAGE for therapeutic exploitation to prevent retinopathy in patients with diabetes.

引用

页码：105 / 120

页数：16

共 157 条

[1]

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy [J].

Abraham, Prema ;

Adelman, Ron A. ;

Alfaro, Daniel Virgil, III ;

Anand, Rajiv ;

Antoszyk, Andrew ;

Bergsma, Donald ;

Hartnett, Mary Elizabeth ;

Brucker, Alexander J. ;

Carr, Tyree ;

Casey, Raynor C. ;

Rubino, John ;

Chandler, Thomas W. ;

Charles, Steven ;

Chaudhry, Nauman ;

Combs, James ;

Doft, Bernard ;

Young, Lucy H. Y. ;

Drouilhet, John H. ;

Dugel, Pravin U. ;

Feman, Stephen S. ;

Finkelstein, Daniel ;

Foster, Robert E. ;

Petersen, Michael R. ;

Fox, Gregory ;

Garretson, Bruce ;

Gieser, Jon P. ;

Gentile, Ronald C. ;

Giovinazzo, Vincent ;

Glazer, Louis ;

Goodart, Roy A. ;

Gottlieb, Justin ;

Greven, Craig ;

Grizzard, William S. ;

Hainsworth, Dean P. ;

Halperin, Lawrence ;

Heier, Jeffrey S. ;

Jackson, William ;

Kubacki, Joseph J. ;

Kanter, Eric D. ;

Keyser, Bruce ;

Kingsley, Ronald ;

Ko, Paula ;

Kokame, Gregg T. ;

Kuppermann, Baruch ;

Lambert, H. Michael ;

Lewis, Hilel ;

Lewis, Richard Alan ;

Marcus, Dennis ;

Nussbaum, Julian ;

Maturi, Raj K. .

OPHTHALMOLOGY, 2006, 113 (12) :2221-2230

[2]

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats [J].

Alderson, NL ;

Chachich, ME ;

Youssef, NN ;

Beattie, RJ ;

Nachtigal, M ;

Thorpe, SR ;

Baynes, JW .

KIDNEY INTERNATIONAL, 2003, 63 (06) :2123-2133

[3]

[Anonymous], 1990, Arch Ophthalmol, V108, P1234

[4]

Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543

[5]

Efficacy of N-acetylcarnosine in the treatment of cataracts [J].

Babizhayev M.A. ;

Deyev A.I. ;

Yermakova V.N. ;

Semiletov Y.A. ;

Davydova N.G. ;

Doroshenko V.S. ;

Zhukotskii A.V. ;

Goldman I.M. .

Drugs in R & D, 2002, 3 (2) :87-103

[6]

Advanced glycation end-product cross-link breakers - A novel approach to cardiovascular pathologies related to the aging process [J].

Bakris, GL ;

Bank, AJ ;

Kass, DA ;

Neutel, JM ;

Preston, RA ;

Oparil, S .

AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (12) :23S-30S

[7]

The RAGE axis in early diabetic retinopathy [J].

Barile, GR ;

Pachydaki, SI ;

Tari, SR ;

Lee, SE ;

Donmoyer, CM ;

Ma, WC ;

Rong, LL ;

Buciarelli, LG ;

Wendt, T ;

Hörig, H ;

Hudson, BI ;

Qu, W ;

Weinberg, AD ;

Yan, SF ;

Schmidt, AM .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (08) :2916-2924

[8]

Glycoxidation and lipoxidation in atherogenesis [J].

Baynes, JW ;

Thorpe, SR .

FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716

[9]

The role of AGEs in aging: causation or correlation [J].

Baynes, JW .

EXPERIMENTAL GERONTOLOGY, 2001, 36 (09) :1527-1537

[10]

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy [J].

Bolton, WK ;

Cattran, DC ;

Williams, ME ;

Adler, SG ;

Appel, GB ;

Cartwright, K ;

Foiles, PG ;

Freedman, BI ;

Raskin, P ;

Ratner, RE ;

Spinowitz, BS ;

Whittier, FC ;

Wuerth, JP .

AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) :32-40

← 1 2 3 4 5 6 7 8 9 10 →